Literature DB >> 16761994

Consensus on extra-hepatic portal vein obstruction.

Shiv Kumar Sarin1, Jose D Sollano, Yogesh Kumar Chawla, Deepak Amarapurkar, Saeed Hamid, Makoto Hashizume, Wasim Jafri, Ashish Kumar, Masatoshi Kudo, Laurentius A Lesmana, Barjesh C Sharma, Gamal Shiha, H Janaka de Silva.   

Abstract

The Asian Pacific Association for the Study of the Liver (APASL) had set up a working party on portal hypertension in 2002 with a mandate to develop consensus on various aspects of portal hypertension. The first of these consensuses has been developed on extra-hepatic portal vein obstruction (EHPVO). It was discussed and prepared by the experts in this field from the Asian region and was presented at the annual meeting of the APASL, at Bali in August 2005. This article summarizes all the consensus statements approved by the APASL on various aspects of EHPVO.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16761994     DOI: 10.1111/j.1478-3231.2006.01269.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  55 in total

Review 1.  Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.

Authors:  Valerio De Stefano; Ida Martinelli
Journal:  Intern Emerg Med       Date:  2010-06-08       Impact factor: 3.397

2.  Portal biliopathy in patients with non-cirrhotic portal hypertension: does the type of surgery affect outcome?

Authors:  Somnath Chattopadhyay; Mahendran Govindasamy; Punit Singla; Vibha Varma; Naimish Mehta; Vinay Kumaran; Samiran Nundy
Journal:  HPB (Oxford)       Date:  2012-05-03       Impact factor: 3.647

Review 3.  Extrahepatic Portal Venous Obstruction: What Should be the Mainstay of Treatment?

Authors:  Richa Lal; Moinak Sen Sarma; Manish K Gupta
Journal:  Indian J Pediatr       Date:  2017-06-14       Impact factor: 1.967

4.  Bile duct stricture caused by portal biliopathy.

Authors:  Vidhyachandra Gandhi; Sanjay Nagral
Journal:  Indian J Gastroenterol       Date:  2009 Jul-Aug

5.  Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding.

Authors:  Ayman Yosry Abd ElRahim; Rabab Fouad; Marwa Khairy; Aisha Elsharkawy; Waleed Fathalah; Haytham Khatamish; Omayma Khorshid; Mona Moussa; Moataz Seyam
Journal:  Hepatol Int       Date:  2017-11-28       Impact factor: 6.047

6.  Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Soon Koo Baik; Yusuf Bayraktar; Yogesh Kumar Chawla; Gourdas Choudhuri; Jin Wook Chung; Roberto de Franchis; H Janaka de Silva; Hitendra Garg; Pramod Kumar Garg; Ahmed Helmy; Ming-Chih Hou; Wasim Jafri; Ji-Dong Jia; George K Lau; Chang-Zheng Li; Hock Foong Lui; Hitoshi Maruyama; Chandra Mohan Pandey; Amrender S Puri; Rungsun Rerknimitr; Peush Sahni; Anoop Saraya; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose D Sollano; Justin Wu; Rui Yun Xu; Surender Kumar Yachha; Chunqing Zhang
Journal:  Hepatol Int       Date:  2011-02-19       Impact factor: 6.047

Review 7.  Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review.

Authors:  T C Hall; G Garcea; M Metcalfe; D Bilku; A R Dennison
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 8.  [Portosystemic shunt surgery between TIPS and liver transplantation].

Authors:  G Puhl; S Gül; P Neuhaus
Journal:  Chirurg       Date:  2011-10       Impact factor: 0.955

9.  Pattern of branching of the left portal vein: an anatomo-radiological study.

Authors:  Veronica Macchi; Andrea Porzionato; Aldo Morra; Giovanni Franco Zanon; Raffaele De Caro
Journal:  Surg Radiol Anat       Date:  2015-02-03       Impact factor: 1.246

10.  Extrahepatic portal venous obstruction: The effects of early ligation of splenic artery during splenectomy.

Authors:  Suhasini Gazula; D K Pawar; T Seth; C S Bal; V Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.